Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pleckstrin homology-like domain family B member 1 (PHLDB1) is a cytoplasmic protein highly expressed in brain and adipose tissue, with a critical role in insulin signaling. It contains a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides (notably PI(3,4)P₂ and PI(3,4,5)P₃), and an N-terminal forkhead-associated (FHA) domain that binds phosphorylated threonine and tyrosine residues. Upon insulin stimulation, PHLDB1 translocates to the plasma membrane where it enhances Akt phosphorylation, leading to increased GLUT4 translocation and glucose uptake in adipocytes. Genetic polymorphisms near PHLDB1 are associated with glioma risk, and its modulation of the Akt pathway may contribute to metabolic changes observed in certain cancers. PHLDB1 functions predominantly as a scaffold/adaptor protein and is not a classic therapeutic target. It is also involved in regulating cytoskeletal dynamics and adhesion at the basal cortex of cells.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pleckstrin homology-like domain family B member 1 (PHLDB1).